Shiseido recalls retinol serum: risk of photodermatitis https://ymaho.com/shiseido-recalls-retinol-serum-risk-of-photodermatitis
Shiseido recalls batch Night Reform No. B327 due to risk of photodermatitis. Learn the causes, consequences, and forecasts. Check your serum now.
Thai Drama: Government Agency Liked 18+ Stream — Scandal https://ymaho.com/thai-drama-government-agency-liked-18-stream-scandal
Account of Thailand's Ministry of Health Liked 18+ Stream. Officials Excuse with 'Fact-Checking'. We Analyze the Scandal, Memes, and Data Leak — Read Details.
Risk of global recession: OECD forecast 2026 https://ymaho.com/risk-of-global-recession-oecd-forecast-2026
OECD lowered growth forecast to 2.8% and warned of recession risk due to Middle East conflict. Analysis of consequences for investors and markets. Read.
Risk of Fed rate hike in 2026 due to independence https://ymaho.com/risk-of-fed-rate-hike-in-2026-due-to-independence
Markets are pricing in a Fed rate hike by end of 2026 amid uncertainty over the regulator's independence. Analysis of risks, scenarios, and consequences for investors. Learn more.
DeFi Risk Management Exit: What It Means for Lending https://ymaho.com/defi-risk-management-exit-what-it-means-for-lending
A core risk team left a major lending network. Learn why funding gaps in decentralized finance matter and how it affects platform safety.
Russian banks increased cash loan issuance by 35%: risk analysis https://ymaho.com/russian-banks-increased-cash-loan-issuance-by-35-risk-analysis
35% growth in cash loan issuance — a harbinger of defaults. Delinquency reached a record, rejections exceeded 80%. Read market analysis and forecasts.
Bab al-Mandeb Closure Risk: Impact on Global Trade & Prices https://ymaho.com/bab-al-mandeb-closure-risk-impact-on-global-trade-prices
Learn how closing a key Red Sea shipping lane could raise fuel and goods prices worldwide—and why it matters to you.
Enspryng reduced the risk of relapses in MOGAD by 68% https://ymaho.com/enspryng-reduced-the-risk-of-relapses-in-mogad-by-68
Genentech proved the efficacy of satralizumab in a rare autoimmune disease. The risk of attacks decreased by 68%, new lesions by 79%. Learn how the first targeted drug fills the niche of empirical therapy.
AI detects heart disease risk from mammography: JMIR study https://ymaho.com/ai-detects-heart-disease-risk-from-mammography-jmir-study
Learn how an AI model based on mammography assesses cardiovascular disease risk. New JMIR study: breast arterial calcification as a marker for MACE. Read the details!
Diamondback Energy hedges risk of US oil export ban https://ymaho.com/diamondback-energy-hedges-risk-of-us-oil-export-ban
Diamondback Energy bought put options for $70 million, hedging against a US oil export ban. Find out why this is a warning signal for the market. Read the analysis.